Rick Matthews: Powerful Perspective from Erin and the NBCA Team
Rick Matthews, Senior Vascular Consultant at Argon Medical Devices, Inc., reposted from Erin VanDyke on LinkedIn:
”Powerful perspective from Erin and the NBCA team.
A VTE Center of Excellence isn’t a “badge” — it’s a culture: prevention, rapid diagnosis, coordinated treatment, follow-up, and community awareness.
The in-person site visit matters because it shows how the team actually works together when minutes count.”
Quoting Erin VanDyke‘s post:
”’Why do you do in-person site visits for COE designation?’
It’s a question I get asked often — and honestly, it’s one of my favorite parts of the process to talk about.
At National Blood Clot Alliance, we believe that achieving a Center of Excellence designation should reflect more than the strength of one service line. It should represent a hospital-wide commitment to improving every aspect of VTE prevention, diagnosis, treatment, follow-up, and community awareness.
That’s why the site visit matters so much. Being there in person allows us to see and feel the culture — how the team communicates, how barriers are approached, and how deeply VTE awareness is woven into the organization.
It gives us a chance to meet the people who make the work happen — from the physicians and APPs to the nurses, pharmacists, and administrators — and to have honest conversations about what’s working, what’s not, and where we can help.
The goal isn’t just to evaluate readiness for designation; it’s to partner in building something sustainable.
To use objective data to refine pathways, strengthen careflows, and ultimately deliver the best possible outcomes for patients.
Because for us, the COE designation isn’t a finish line — it’s the beginning of an ongoing collaboration to grow, evolve, and raise the bar for VTE care together.”
Stay updated with Hemostasis Today.
-
Feb 23, 2026, 18:13Fight4Hematology Supports Research and Empowers the Next Generation – ASH
-
Feb 23, 2026, 17:59Wolfgang Miesbach: Real-World Evidence of Emicizumab on Joint Outcomes in Hemophilia A
-
Feb 23, 2026, 17:56Shiny K Kajal: The Transfusion Reaction We Often Miss
-
Feb 23, 2026, 17:53Radheshyam Meher: Contributing to the Transfusion Evidence Round-Up for International Childhood Cancer Day 2026
-
Feb 23, 2026, 17:46Mahesan Subramaniam: The Physiological Impact of Anger on Immunity
-
Feb 23, 2026, 17:42Bryan Fry: First Evidence That Bothrops atrox Venom Directly Activates Human Factor VII
-
Feb 23, 2026, 17:34Bastu Odoka: Why Blood Should NOT be Left at the Bedside to ‘Warm’
-
Feb 23, 2026, 17:28Henry Burkitt: Patients Are Challenging How the Medicines Policy System Works in England
-
Feb 23, 2026, 16:50Mutaz Al‑Sabah: Interesting Webinar on FH in Women is Now Available to Watch